PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.\', \'Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, USA.\', \'School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, CF10 3NB, Cardiff, UK.\', \'Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.\', \'Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA. jxj321@psu.edu.\', \'Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, USA. jxj321@psu.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s42003-022-03090-9
?:hasPublicationType
?:journal
  • Communications biology
is ?:pmid of
?:pmid
?:pmid
  • 35217718
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all